Oxytrol
Intended to manage overactive bladder symptoms to support bladder function.
Strengths: 5mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Kentera
- Therapeutic class
Antispasmodic
- Pharmacological class
Anticholinergic
- Minor side effects
application site erythema; dry mouth; constipation; pruritus
- Moderate side effects
somnolence; blurred vision; nausea; dry eyes
- Dosage forms
Transdermal patch
- Administration route
Transdermal use
- Patient summary
Intended to manage overactive bladder symptoms to support bladder function.
- Prescription status
POM
- Onset Time
2–4 hours
- Duration
3–4 days (per patch)
- Storage instructions
Store in original packaging at room temperature.
- Drug interactions
other anticholinergics; potassium
- Age restrictions
Not recommended for children.
Contraindications
urinary retention; gastric retention; uncontrolled angle-closure glaucoma; myasthenia gravis
Precautions and warnings
avoid prolonged sun exposure; keep the site dry before application; may impair cognitive function in elderly
Serious side effects
anaphylaxis — requires immediate medical attention; urinary retention — requires immediate medical attention
Mechanism of action
Inhibits acetylcholine binding at muscarinic receptors, relaxing bladder smooth muscle to reduce involuntary contractions and urgency.
Pregnancy and breastfeeding
Pregnancy: Use only if potential benefit justifies risk. Breastfeeding: Avoid use.
Oxytrol
Intended to manage overactive bladder symptoms to support bladder function.
Editorial Notes
- Active ingredient(s): Oxybutynin
- Listed indication(s): Overactive Bladder
Available option
- 90 tablets - 5 mg210-5-mg-1338